Gesellschaft für Therapieforschung mbH Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04552327
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gesellschaft für Therapieforschung mbH | GKM Gesellschaft für Therapieforschung mbH